BioCryst Launches ORLADEYO® (berotralstat) in Portugal

Go back to BioCryst Launches ORLADEYO® (berotralstat) in Portugal
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) Delayed: 8.98 -0.26 (2.81%)
Previous Close $9.24    52 Week High $10.98 
Open $9.17    52 Week Low $1.63 
Day High $9.25    P/E N/A 
Day Low $8.93    EPS $-0.68 
Volume 2,928,402